← Back to all trials
Not Yet Recruiting
NCT07657078
Meleis' Transition Theory-Based Education and Counseling Program in Menopausal Women
Conditions: Menopause, Menopausal Symptoms, Perimenopausal Depression
Sex: Female
Ages: 45 Years – 55 Years
Healthy volunteers: No
Phase: NA
Enrollment: 114
Sponsor: Ankara Medipol University
Location: Ankara Medipol University Ankara
Summary
This randomized controlled trial aims to evaluate the effectiveness of a Meleis' Transition Theory-based education and counseling program on menopausal symptoms, perimenopausal depression, and menopause-specific quality of life among naturally menopausal women aged 45 to 55 years.
Participants will be randomly assigned to either the intervention group or the control group. The intervention group will receive a structured four-week education and counseling program based on Meleis' Transition Theory, supported by a secure online messaging group and follow-up counseling sessions. The control group will receive routine care and standard information during the study period and will be offered a one-day educational session after completion of the final assessment.
The outcomes will be measured at baseline and Week 16 using the Menopause Rating Scale, the Perimenopausal Depression Scale, and the Menopause-Specific Quality of Life Questionnaire-II.
Eligibility Criteria
Inclusion Criteria:
* Female participants aged 45 to 55 years
* Naturally menopausal women
* Menopause duration not exceeding 2 years
* Experiencing menopausal symptoms
* Sexually active
* Able to read and write Turkish
* Willing to participate voluntarily
* Able to provide written informed consent
* Not currently receiving hormone replacement therapy
* No history of psychiatric disorders
* No previous menopause-related education
Exclusion Criteria:
* Failure to continue participation in the study
* Failure to attend education and counseling sessions
* Withdrawal from the study at any time
* Withdrawal of informed consent
* Loss to follow-up
Source: ClinicalTrials.gov (NCT07657078). StuddyBuddy aggregates publicly available trial information.